Trial Profile
Pharmacokinetic and toxicodynamic study of linezolid in patients with Gram-positive bacterial infections
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Linezolid (Primary)
- Indications Gram-positive infections
- Focus Pharmacodynamics; Pharmacokinetics
- 03 Dec 2015 New trial record